NM_032122.5:c.886C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032122.5(DTNBP1):​c.886C>T​(p.Pro296Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00239 in 1,614,228 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P296R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.012 ( 37 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 42 hom. )

Consequence

DTNBP1
NM_032122.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.82

Publications

7 publications found
Variant links:
Genes affected
DTNBP1 (HGNC:17328): (dystrobrevin binding protein 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. A similar protein in mouse is a component of a protein complex termed biogenesis of lysosome-related organelles complex 1 (BLOC-1), and binds to alpha- and beta-dystrobrevins, which are components of the dystrophin-associated protein complex (DPC). Mutations in this gene are associated with Hermansky-Pudlak syndrome type 7. This gene may also be associated with schizophrenia. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
DTNBP1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003545642).
BP6
Variant 6-15523145-G-A is Benign according to our data. Variant chr6-15523145-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 262013.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0123 (1867/152336) while in subpopulation AFR AF = 0.0415 (1725/41572). AF 95% confidence interval is 0.0399. There are 37 homozygotes in GnomAd4. There are 886 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 37 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DTNBP1NM_032122.5 linkc.886C>T p.Pro296Ser missense_variant Exon 10 of 10 ENST00000344537.10 NP_115498.2 Q96EV8-1A0A0S2Z5U8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DTNBP1ENST00000344537.10 linkc.886C>T p.Pro296Ser missense_variant Exon 10 of 10 1 NM_032122.5 ENSP00000341680.6 Q96EV8-1

Frequencies

GnomAD3 genomes
AF:
0.0123
AC:
1867
AN:
152218
Hom.:
37
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0416
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00759
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00316
AC:
794
AN:
251492
AF XY:
0.00235
show subpopulations
Gnomad AFR exome
AF:
0.0423
Gnomad AMR exome
AF:
0.00225
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000439
Gnomad OTH exome
AF:
0.00195
GnomAD4 exome
AF:
0.00136
AC:
1990
AN:
1461892
Hom.:
42
Cov.:
31
AF XY:
0.00124
AC XY:
900
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0464
AC:
1553
AN:
33480
American (AMR)
AF:
0.00284
AC:
127
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000568
AC:
49
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00433
AC:
25
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000378
AC:
42
AN:
1112012
Other (OTH)
AF:
0.00321
AC:
194
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
136
272
408
544
680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0123
AC:
1867
AN:
152336
Hom.:
37
Cov.:
33
AF XY:
0.0119
AC XY:
886
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.0415
AC:
1725
AN:
41572
American (AMR)
AF:
0.00758
AC:
116
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68024
Other (OTH)
AF:
0.00992
AC:
21
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
89
178
266
355
444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00461
Hom.:
27
Bravo
AF:
0.0150
ESP6500AA
AF:
0.0422
AC:
186
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00372
AC:
452
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 09, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
7.9
DANN
Benign
0.60
DEOGEN2
Benign
0.059
T;.;T;.;.
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.55
D
LIST_S2
Uncertain
0.91
D;D;D;D;D
MetaRNN
Benign
0.0035
T;T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.0
L;.;.;.;.
PhyloP100
2.8
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.39
N;N;.;.;N
REVEL
Benign
0.086
Sift
Benign
0.91
T;T;.;.;T
Sift4G
Benign
1.0
T;T;T;T;.
Polyphen
0.0090
B;.;.;.;.
Vest4
0.065
MVP
0.29
MPC
0.15
ClinPred
0.0083
T
GERP RS
4.5
Varity_R
0.022
gMVP
0.069
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74907982; hg19: chr6-15523376; API